177Lu-FC516

N/A

Report date: 2026/04/22 20:01:10

NME

Base Information

Drug Name177Lu-FC516

Drug Alias Name177Lu-FC516

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agent

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesFindCure Biosciences (ZhongShan) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesFindCure Biosciences (ZhongShan) Co Ltd

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A